Click Here for 5% Off Your First Aladdin Purchase!

AM1241 - ≥98%, high purity , CAS No.444912-48-5, Agonist of CB 2 receptor

  • Moligand™
  • ≥98%
Item Number
A129838
Grouped product items
SKUSizeAvailabilityPrice Qty
A129838-1mg
1mg
In stock
$26.90
A129838-5mg
5mg
In stock
$102.90
A129838-10mg
10mg
In stock
$149.90
A129838-25mg
25mg
In stock
$252.90
A129838-50mg
50mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$454.90

Potent, selective CB 2 agonist

View related series
CB2 receptor Agonist

Basic Description

Synonyms444912-48-5|AM1241|AM-1241|(2-iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H-indol-3-yl)methanone|(R,S)-AM1241|DLM851L3RD|(1-(Methylpiperidin-2-ylmethyl)-3-(2-iodo-5-nitrobenzoyl)indole)|(2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsAM-1241 is a protean agonist of CB2 based on the different effect observed in various assays (calcium influx, extracellular signal-regulated kinase (ERK) phosphorylatin and cAMP measurement)) and on the switch from neutral antagonism to agonism in the cAM
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionAgonist of CB 2 receptor
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.
(R,S)-AM1241, a selective CB2 cannabinoid receptor agonist, has been used to study neuropathic pain in animal models

Associated Targets

CNR1 Tclin Cannabinoid receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CNR2 Tchem Cannabinoid receptor 2 12 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (2-iodo-5-nitrophenyl)-[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone
INCHI InChI=1S/C22H22IN3O3/c1-24-11-5-4-6-16(24)13-25-14-19(17-7-2-3-8-21(17)25)22(27)18-12-15(26(28)29)9-10-20(18)23/h2-3,7-10,12,14,16H,4-6,11,13H2,1H3
InChi Key ZUHIXXCLLBMBDW-UHFFFAOYSA-N
Canonical SMILES CN1CCCCC1CN2C=C(C3=CC=CC=C32)C(=O)C4=C(C=CC(=C4)[N+](=O)[O-])I
Isomeric SMILES CN1CCCCC1CN2C=C(C3=CC=CC=C32)C(=O)C4=C(C=CC(=C4)[N+](=O)[O-])I
WGK Germany 3
Alternate CAS 444912-48-5
PubChem CID 10141893
MeSH Entry Terms AM 1241;AM1241
Molecular Weight 503.33

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

5 results found

Lot NumberCertificate TypeDateItem
K2103414Certificate of AnalysisAug 04, 2023 A129838
K2103416Certificate of AnalysisAug 04, 2023 A129838
K2103424Certificate of AnalysisAug 04, 2023 A129838
K2103425Certificate of AnalysisAug 04, 2023 A129838
K2103427Certificate of AnalysisAug 04, 2023 A129838

Chemical and Physical Properties

SolubilityDMSO 101 mg/mL Water <1 mg/mL Ethanol <1 mg/mL

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H334:May cause allergy or asthma symptoms or breathing difficulties if inhaled

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P284:[In case of inadequate ventilation] Wear respiratory protection.

P271:Use only outdoors or in a well-ventilated area.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

P342+P316:If experiencing respiratory symptoms: Get emergence medical help immediately.

WGK Germany 3

Related Documents

References

1. Niu J et al..  (2017)  Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12and P2Y13receptors in neuropathic pain rats..  J Neuroinflammation,  14  (185).  [PMID:28899427]
2. Zhou S et al..  (2021)  Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing..  J Cell Mol Med,  25  (18): (8957-8972).  [PMID:34414658]
3. Li MH et al..  (2017)  Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain..  J Neurosci,  37  (3): (626-636).  [PMID:28100744]
4. Abd El-Rahman SS & Fayed HM.  (2022)  Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NF?Bp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats..  PLoS One,  17  (3): (e0265961).  [PMID:35349580]
5. Ali AM et al..  (2021)  Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide..  Chem Biol Interact,  336  (109398).  [PMID:33503444]

Solution Calculators